Development status and prospects of cell therapy industry in China / 中国肿瘤生物治疗杂志

ABSTRACT

@# Cell therapy includes stem cell therapy and immunotherapy for multiple diseases including cancer. With the progress in life science and medicine as well as people’s increasing demands for health, cell therapy has become an important frontier research field. Constantly emerged innovative theories, technologies and clinical outcomes of cell therapy have laid a solid foundation for the development of cell therapy industrialization. Now some cell therapy products have already been approved by the regulatory authorities abroad; and in China, cell therapy is in a period of great opportunities. Therefore, how to optimize the supervision and guiding system and provisions, to better stimulate the vitality of research and transformation, to create more benefits for patients and to promote the development of the industry in an orderly manner have become an issues that worth deep consideration. In this paper, we discussed the current progress on stem cell therapy and immunotherapy represented by chimeric antigen receptor T-Cell (CAR-T) in both domestic and overseas, and the industry supervision of cell therapy in China; in addition, we also put forward some suggestions for the development of cell therapy in China for the reference of peers in this field.